FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 803 - Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases - Authorized by Law

GENERAL INFORMATION

Committee Name	Board of Scientific Counselors, National Institute of Diabetes and Digestive and Kidney Diseases	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	803
Original Establishment Date	11/20/1985	Committee Status	Chartered
Actual Termination Date		Committee URL	https://www.niddk.nih.gov/about-niddk/advisory-...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	8
Terminated This FY	No	Designated Fed Officer Position Title*	SCIENTIFIC DIRECTOR
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	12/1/1986	Designated Federal Officer First Name*	MICHAEL
Date Of Renewal Charter		Designated Federal Officer Middle Name	W.
Projected Termination Date		Designated Federal Officer Last Name*	KRAUSE
Exempt From Renewal*	Yes	Designated Federal Officer Suffix	PH.D.
Specific Termination Authority		Designated Federal Officer Phone*	(301) 402-7044
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*	(301) 496-0201
Specific Establishment Authority*	42 U.S.C. 282(b)(16)	Designated Federal Officer Email*	michaelkr@mail.nih.gov
Effective Date Of Authority*	11/20/1985
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Other Committee

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	Section 402(b)(9) of the Public Health Service Act states that ...the Director, NIH...shall assure that research at...the National Institutes of Health is subject to review in accordance with section 492. Section 492(b) states that the Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. This Board assesses the quality of the Institute intramural research programs and evaluates the productivity and performance of staff scientists, necessary functions for the operation of a highly effective intramural research program. The Board is composed of recognized biomedical and or behavioral research authorities who represent the forefront of research and technical knowledge and who provide evaluation and peer review of Institute laboratories and staff scientists in the following areas: diabetes, endocrinology, and metabolism; digestive diseases and nutritional disorders; and kidney, urologic and hematological diseases. The Board continues to provide indispensable evaluation and advisory functions in the science management of the intramural research programs. The Board normally holds two formal meetings each year for peer review of each laboratory and the chairman and individual Board members are frequently consulted for advice on staff appointments and program development. In FY2024 three meetings were held. The October 12, 2023 meeting the board reviewed the following labs: Laboratory of Biological Modeling and Laboratory of Endocrinology and Receptor Biology. During the April 19, 2024 meeting, the board reviewed: Digestive Disease Branch, Diabetes, Endocrinology, & Obesity Branch, Laboratory of Biochemistry & Genetics, Laboratory of Cell & Molecular Biology, Laboratory of Endocrinology & Receptor Biology and Metabolic Diseases Branch. During the Spring 2024 session, the board reviewed the work of fifteen (15) Principal Investigators and two (2) tenure track Investigators. The Board plans to review the Diabetes, Endocrinology, and Obesity Branch and the Laboratory of Molecular Biology as well as seven (7) Principal Investigators, one of whom is considered for tenure. The Board provides to the National Diabetes and Digestive and Kidney Diseases Advisory Council for review a description of its activities.
How is membership balanced?*	The Board consists of eight members, approximately, who are outstanding authorities knowledgeable in the specialized fields of diabetes, kidney diseases, molecular biology, chemistry, chemical physics, genetics, endocrinology, biochemistry and nutrition. The advisory role of the Board is scientific and substantive. The Board, through periodic visits to the laboratories, assesses the research in progress and evaluates productivity and performance of staff scientists.
How frequent & relevant are cmte mtgs?*	The Board typically holds two meetings each year for the peer review of intramural laboratories on a rotating basis as required by the PHS Act. The Board did not meet during this reporting period. The Board planned on meeting in April of this fiscal year but were required to re-schedule to FY 2025.
Why advice can't be obtained elsewhere?*	The Board is composed of recognized biomedical research authorities from outside the NIH in order to secure unbiased and objective evaluation of intramural research programs. Their recommendations are invaluable because the complex nature of research in each laboratory requires a unique balance and breadth of expertise not available on the NIH staff or from other established resources.
Why close or partially close meetings?	The meetings of the Board were partially closed for the review, discussion, and evaluation of individual programs and projects conducted by the Institute, including consideration of personnel qualifications and performance, the competence of individual investigators, and similar items, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Section 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussions could reveal personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation Remarks	Committee Function: Other - Scientific and Technical Peer Review. Reports: This committee did not produce any reports during this reporting period. Note that the Designated Federal Officer and Committee Decision Maker positions are both held by the Scientific Director of the Institute. The Board advises the Institute on issues associated with the Institute's Intramural Research Program, which is the primary responsibility of the Scientific Director. Dr. Benjamin Humphreys will replace Dr. Jay Horton as Chairperson. The Board typically holds two meetings each year for the peer review of intramural laboratories on a rotating basis as required by the PHS Act. The Board did not meet during this reporting period. The Board planned on meeting in April of this fiscal year but were required to re-schedule to FY 2025.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	Yes
Outcome Increased Customer Satisfaction	No	Action Comment	The Scientific Director and other NIH officials use the recommendations made by the BSC in evaluating the quality of intramural research programs including scientific priorities and resources available. No changes were made to existing laboratory research priorities or resources.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.	Grants Review Comment	Although grant reviews are included in the duties of the Board, there were no grant reviews performed during this fiscal year.
Number Of Recommendations*	85	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	During each meeting the members evaluate the scientific programs of three or four Laboratories/Branches (every Lab/Branch is evaluated once every four years) and reviewed the progress of junior scientists at the midpoint of or during the final year of the six-to-eight year period of their tenure track appointment. The Board made three recommendations during this fiscal year.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Information on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Information on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.	Access Other	Yes
Agency Feedback*	Yes	Access Comment	Contact Designated Federal Officer
Agency Feedback Comment*	Information resulting from closed Board of Scientific Counselors meetings is subject to the Freedom of Information Act. The public can view information on NIH Intramural Research Reports found on the NIH Intramural Research Sourcebook website located at https://oir.nih.gov/sourcebook/intramural-research-communications-resources/annual-reports-bibliographies/	Narrative Description*	NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. NIH works toward that mission by conducting research in its own laboratories. The mission of the Board of Scientific Counselors is to assess the quality of the Institute’s intramural research programs and to evaluate the productivity and performance of intramural scientists in accordance with Section 492(b) of the PHS Act, as amended and shall also, as requested by the Director, NIH, undertake peer review of extramural funding applications as required by section 492(a) of the Public Health Service Act, as amended.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:22 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Health Care Medicine Health and Health Research

Custom Links

Committee Level Reports